Cypher BioFollows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine releaseCommit is poised to nominate its first two clinical development candidates later in ...

Complement 3 glomerulopathy (C3G) is diagnosed with a combination of a clinical evaluation, blood tests, urine tests, and a renal (kidney) biopsy. The only way to definitively diagnose C3G and its ...

Commit Biologics, a biotech company pioneering complement system activation, has appointed Thomas Montgomery Andresen as Chief Executive Officer (CEO), effective 16 March 2026. Thomas, a biotech ...

Researchers have uncovered a potent genetic mechanism that could revolutionize cancer therapy. The immune system naturally generates a molecule known as IL-15, which serves as a defender that triggers ...

TEMPO.CO, Jakarta - Research results show the benefits of using supplement products in helping maintain the body's immune ...

Roche Holding AG ( RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT ...

A longtime couple who coincidentally both have a life-altering disease consider themselves “lucky” to have each other. They ...

Hypertension is often described in simple terms: a chronic condition in which blood pressure remains persistently elevated. Yet behind those numbers o.

Approval based on KOMET Phase III trial results which showed 20% objective response rate in tumour size reductionMISSISSAUGA, ON, March 9, 2026 /CNW/ ...

Researchers at King's College London have discovered that an immune protein best known for protecting the body against ...

A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...